Protocol for the WARM Hearts study: examining cardiovascular disease risk in middle-aged and older women - a prospective, observational cohort study

Alexandra V Rose, Kevin F Boreskie, Jacqueline L Hay, Liam Thompson, Rakesh C Arora, Todd A Duhamel, Alexandra V Rose, Kevin F Boreskie, Jacqueline L Hay, Liam Thompson, Rakesh C Arora, Todd A Duhamel

Abstract

Introduction: Cardiovascular disease (CVD) is a leading cause of death in women. Novel approaches to detect early signs of elevated CVD risk in women are needed. Enhancement of traditional CVD risk assessment approaches through the addition of procedures to assess physical function or frailty as well as novel biomarkers of cardiovascular, gut and muscle health could improve early identification. The Women's Advanced Risk-assessment in Manitoba (WARM) Hearts study will examine the use of novel non-invasive assessments and biomarkers to identify women who are at elevated risk for adverse cardiovascular events.

Methods and analysis: One thousand women 55 years of age or older will be recruited and screened by the WARM Hearts observational, cohort study. The two screening appointments will include assessments of medical history, gender variables, body composition, cognition, frailty status, functional fitness, physical activity levels, nutritional status, quality of life questionnaires, sleep behaviour, resting blood pressure (BP), BP response to moderate-intensity exercise, a non-invasive measure of arterial stiffness and heart rate variability. Blood sample analysis will be used to assess lipid and novel biomarker profiles and stool samples will support the characterisation of gut microbiota. The incidence of the adverse cardiovascular outcomes will be assessed 5 years after screening to compare WARM Hearts approaches to the Framingham Risk Score, the current clinical standard of assessing CVD risk in Canada.

Ethics and dissemination: The University of Manitoba Health Research Ethics Board (7 October 2019) and the St Boniface Hospital Research Review Committee (7 October 2019) approved the trial (Ethics Number HS22576 (H2019:063)). Recruitment started 10 October 2020. Data gathered from the WARM Hearts study will be published in peer-reviewed journals and presented at national and international conferences. Knowledge translation strategies will be created to share our findings with stakeholders who are positioned to implement evidence-informed CVD risk assessment programming.

Trial registration number: NCT03938155.

Keywords: cardiology; preventive medicine; risk management.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
WARM Hearts flow chart. CVD, cardiovascular disease; WARM, Women’s Advanced Risk-assessment in Manitoba.

References

    1. GBD 2016 Causes of Death Collaborators . Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet 2017;390:1151–210. 10.1016/S0140-6736(17)32152-9
    1. Kettner J. Chief provincial public health officer’s report on the health status of manitobans 2010 priorities for prevention: everyone, every place, every day. 272, 2010.
    1. Heart & Stroke 2018 Heart Report . Ms Understood Women’s hearts are victims of a system that is ill-equipped to diagnose, treat and support them, 2018.
    1. Sedlak TL, Lee M, Izadnegahdar M, et al. . Sex differences in clinical outcomes in patients with stable angina and NO obstructive coronary artery disease. Am Heart J 2013;166:38–44. 10.1016/j.ahj.2013.03.015
    1. Norris CM, Yip CYY, Nerenberg KA, et al. . State of the science in women's cardiovascular disease: a Canadian perspective on the influence of sex and gender. J Am Heart Assoc 2020;9:e015634. 10.1161/JAHA.119.015634
    1. Rodondi N, Locatelli I, Aujesky D, et al. . Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS One 2012;7:e34287. 10.1371/journal.pone.0034287
    1. Shlipak MG, Elmouchi DA, Herrington DM, et al. . The incidence of unrecognized myocardial infarction in women with coronary heart disease. Ann Intern Med 2001;134:1043–7. 10.7326/0003-4819-134-11-200106050-00010
    1. O'Callaghan KM. Solutions for disparities for women with heart disease. J Cardiovasc Transl Res 2009;2:518–25. 10.1007/s12265-009-9125-6
    1. Farooqi MAM, Gerstein H, Yusuf S, et al. . Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals. J Am Heart Assoc 2020;9:e014686. 10.1161/JAHA.119.014686
    1. Wang J, Tan G-J, Han L-N, et al. . Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017;14:135–50. 10.11909/j.issn.1671-5411.2017.02.008
    1. Boreskie KF, Oldfield CJ, Hay JL, et al. . Myokines as biomarkers of frailty and cardiovascular disease risk in females. Exp Gerontol 2020;133:1–7. 10.1016/j.exger.2020.110859
    1. Merritt MA, Riboli E, Murphy N, et al. . Reproductive factors and risk of mortality in the European prospective investigation into cancer and nutrition; a cohort study. BMC Med 2015;13:252. 10.1186/s12916-015-0484-3
    1. Canoy D, Beral V, Balkwill A, et al. . Age at menarche and risk of coronary heart disease in the UK Million women study. Int J Epidemiol 2015;44:i52–3. 10.1093/ije/dyv097.200
    1. Atsma F, Bartelink M-LEL, Grobbee DE, et al. . Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265–79. 10.1097/01.gme.0000218683.97338.ea
    1. Lawlor DA, Emberson JR, Ebrahim S, et al. . Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? findings from the British women's heart and health study and the British regional heart study. Circulation 2003;107:1260–4. 10.1161/01.cir.0000053441.43495.1a
    1. Boreskie KF, Kehler DS, Costa EC, et al. . Protocol for the happy hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study. BMJ Open 2017;7:1–9. 10.1136/bmjopen-2017-018249
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:1–42. 10.1136/bmj.e7586
    1. von Elm E, Altman DG, Egger M, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495–9. 10.1016/j.ijsu.2014.07.013
    1. Heidari S, Babor TF, De Castro P, et al. . Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016;1:2. 10.1186/s41073-016-0007-6
    1. Park A. Reachable : Data collection methods for sexual orientation and gender identity. 2016. The Williams Institue, 2016: 1–8.
    1. Bauer G, Title N. Canadian Institutes of health research, 2012.
    1. Pelletier R, Ditto B, Pilote L. A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome. Psychosom Med 2015;77:517–26. 10.1097/PSY.0000000000000186
    1. Pelletier R, Khan NA, Cox J, et al. . Sex versus gender-related characteristics: which predicts outcome after acute coronary syndrome in the young? J Am Coll Cardiol 2016;67:127–35. 10.1016/j.jacc.2015.10.067
    1. O'Neil A, Scovelle AJ, Milner AJ, et al. . Gender/sex as a social determinant of cardiovascular risk. Circulation 2018;137:854–64. 10.1161/CIRCULATIONAHA.117.028595
    1. Hernandez-Martinez A, Martinez-Rosales E, Alcaraz-Ibañez M, et al. . Influence of body composition on arterial stiffness in middle-aged adults: healthy UAL cross-sectional study. Medicina 2019;55. 10.3390/medicina55070334. [Epub ahead of print: 03 Jul 2019].
    1. Ittermann T, Werner N, Lieb W, et al. . Changes in fat mass and fat-free-mass are associated with incident hypertension in four population-based studies from Germany. Int J Cardiol 2019;274:372–7. 10.1016/j.ijcard.2018.09.035
    1. Srikanthan P, Horwich TB, Tseng CH. Relation of muscle mass and fat mass to cardiovascular disease mortality. Am J Cardiol 2016;117:1355–60. 10.1016/j.amjcard.2016.01.033
    1. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79:379–84. 10.1093/ajcn/79.3.379
    1. Canadian Society of Exercise Physiology . CSEP certified personal trainer ® update to Pre-Participation screening procedures CSEP certified personal trainer ®, 2017: 2–4.
    1. Ling CHY, de Craen AJM, Slagboom PE, et al. . Accuracy of direct segmental Multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr 2011;30:610–5. 10.1016/j.clnu.2011.04.001
    1. Sato S, Demura S, Kitabayashi T, et al. . Segmental body composition assessment for obese Japanese adults by single-frequency bioelectrical impedance analysis with 8-point contact electrodes. J Physiol Anthropol 2007;26:533–40. 10.2114/jpa2.26.533
    1. Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc 2008;56:2211–6. 10.1111/j.1532-5415.2008.02008.x
    1. Fried LP, Tangen CM, Walston J, et al. . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–57. 10.1093/gerona/56.3.m146
    1. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401. 10.1177/014662167700100306
    1. Nowak Z, Plewa M, Skowron M, et al. . Paffenbarger physical activity questionnaire as an additional tool in clinical assessment of patients with coronary artery disease treated with angioplasty. Kardiol Pol 2010;68:32–9.
    1. Clegg A, Young J, Iliffe S, et al. . Frailty in elderly people. Lancet 2013;381:752–62. 10.1016/S0140-6736(12)62167-9
    1. Nasreddine ZS, Phillips NA, Bédirian V, et al. . The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 2001;1:323–36. 10.1100/tsw.2001.58
    1. Searle SD, Mitnitski A, Gahbauer EA, et al. . A standard procedure for creating a frailty index. BMC Geriatr 2008;8:24. 10.1186/1471-2318-8-24
    1. Rikli RE, Jones CJ. Development and validation of a functional fitness test for Community-Residing older adults. J Aging Phys Act 1999;7:129–61. 10.1123/japa.7.2.129
    1. Beatty AL, Schiller NB, Whooley MA. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med 2012;172:1096–102. 10.1001/archinternmed.2012.2198
    1. Fleg JL, Piña IL, Balady GJ, Chaitman BR, Fletcher B, et al. . Assessment of functional capacity in clinical and research applications: an Advisory from the Committee on exercise, rehabilitation, and prevention, Council on clinical cardiology, American heart association. Circulation 2000;102:1591–7. 10.1161/01.cir.102.13.1591
    1. Redberg RF, Whiteman MK, a FJ, et al. . And all-cause death in asymptomatic women. Methods 2007;290:1600–7.
    1. Tarvainen MP, Niskanen J-P, Lipponen JA, et al. . Kubios HRV--heart rate variability analysis software. Comput Methods Programs Biomed 2014;113:210–20. 10.1016/j.cmpb.2013.07.024
    1. Tang WHW, Hazen SL. The gut microbiome and its role in cardiovascular diseases. Circulation 2017;135:1008–10. 10.1161/CIRCULATIONAHA.116.024251
    1. Ahmad AF, Dwivedi G, O'Gara F, O’Gara F, et al. . The gut microbiome and cardiovascular disease: current knowledge and clinical potential. Am J Physiol Heart Circ Physiol 2019;317:H923–38. 10.1152/ajpheart.00376.2019
    1. Lau K, Srivatsav V, Rizwan A, et al. . Bridging the gap between gut microbial dysbiosis and cardiovascular diseases. Nutrients 2017;9. 10.3390/nu9080859. [Epub ahead of print: 10 Aug 2017].
    1. Anderson TJ, Grégoire J, Pearson GJ, et al. . Canadian cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016;2016:1263–82.
    1. Nerenberg KA, Zarnke KB, Leung AA, et al. . Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol 2018;34:506–25. 10.1016/j.cjca.2018.02.022
    1. Jones CR, Taylor K, Chowienczyk P, et al. . A validation of the Mobil O graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000;5:233–8. 10.1097/00126097-200008000-00007
    1. Agabiti-Rosei E, Mancia G, O'Rourke MF, et al. . Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007;50:154–60. 10.1161/HYPERTENSIONAHA.107.090068
    1. Waddell TK, Dart AM, Medley TL, et al. . Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension 2001;38:927–31. 10.1161/hy1001.096107
    1. Roman MJ, Devereux RB, Kizer JR, et al. . Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the strong heart study. Hypertension 2007;50:197–203. 10.1161/HYPERTENSIONAHA.107.089078
    1. Hametner B, Wassertheurer S, Kropf J, et al. . Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit 2013;18:173–6. 10.1097/MBP.0b013e3283614168
    1. Feistritzer H-J, Reinstadler SJ, Klug G, et al. . Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 2015;10:1–12. 10.1371/journal.pone.0116862
    1. Weiss W, Gohlisch C, Harsch-Gladisch C, et al. . Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 2012;17:128–31. 10.1097/MBP.0b013e328353ff63
    1. Wassertheurer S, Kropf J, Weber T, et al. . A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens 2010;24:498–504. 10.1038/jhh.2010.27
    1. Shoji T, Maekawa K, Emoto M, et al. . Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis 2010;210:145–9. 10.1016/j.atherosclerosis.2009.11.013
    1. Pereira T, Maldonado J, Pereira L, et al. . Aortic stiffness is an independent predictor of stroke in hypertensive patients. Arq Bras Cardiol 2013;100:437–43. 10.5935/abc.20130079
    1. Choi CU, Park EB, Suh SY, et al. . Impact of aortic stiffness on cardiovascular disease in patients with chest pain: assessment with direct intra-arterial measurement. Am J Hypertens 2007;20:1163–9. 10.1016/j.amjhyper.2007.07.004
    1. Cruickshank K, Riste L, Anderson SG, et al. . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085–90. 10.1161/01.cir.0000033824.02722.f7
    1. Mattace-Raso FUS, van der Cammen TJM, Hofman A, et al. . Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006;113:657–63. 10.1161/CIRCULATIONAHA.105.555235
    1. Kim D, Ha J-W. Hypertensive response to exercise: mechanisms and clinical implication. Clin Hypertens 2016;22:16–19. 10.1186/s40885-016-0052-y
    1. Schultz MG, Hare JL, Marwick TH, et al. . Masked hypertension is "unmasked" by low-intensity exercise blood pressure. Blood Press 2011;20:284–9. 10.3109/08037051.2011.566251
    1. Singh JP, Larson MG, Manolio TA, et al. . Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. Circulation 1999;99:1831–6. 10.1161/01.cir.99.14.1831
    1. Duprez DA, Florea N, Zhong W, et al. . Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations. J Am Soc Hypertens 2011;5:401–9. 10.1016/j.jash.2011.05.001
    1. Craig CL, Marshall AL, Sjöström M, et al. . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95. 10.1249/01.MSS.0000078924.61453.FB
    1. Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. Am J Prev Med 2004;26:407–18. 10.1016/j.amepre.2004.02.007
    1. Rodriguez BL, Curb JD, Burchfiel CM, et al. . Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men. The Honolulu heart program. Circulation 1994;89:2540–4. 10.1161/01.cir.89.6.2540
    1. Kim TH, Jo M-W, Lee S-il, et al. . Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res 2013;22:2245–53. 10.1007/s11136-012-0331-3
    1. Koh D, Abdullah AMKbin, Wang P, et al. . Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PLoS One 2016;11:e0165555–9. 10.1371/journal.pone.0165555
    1. Dyer MTD, Goldsmith KA, Sharples LS, et al. . A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13–12. 10.1186/1477-7525-8-13
    1. Nolan CM, Longworth L, Lord J, et al. . The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax 2016;71:493–500. 10.1136/thoraxjnl-2015-207782
    1. Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res 2014;23:977–89. 10.1007/s11136-013-0537-z
    1. Buysse DJ, Reynolds CF, Monk TH, et al. . The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213. 10.1016/0165-1781(89)90047-4
    1. Kwok CS, Kontopantelis E, Kuligowski G, et al. . Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. J Am Heart Assoc 2018;7:e008552. 10.1161/JAHA.118.008552
    1. Keller HH, Goy R, Kane S-L. Validity and reliability of screen II (seniors in the community: risk evaluation for eating and nutrition, version II). Eur J Clin Nutr 2005;59:1149–57. 10.1038/sj.ejcn.1602225
    1. Lim SS, Vos T, Flaxman AD, et al. . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2224–60. 10.1016/S0140-6736(12)61766-8
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x
    1. Blumenthal JA. Depression and coronary heart disease: association and implications for treatment. Cleve Clin J Med 2008;75 Suppl 2:48–53. 10.3949/ccjm.75.suppl_2.s48
    1. Doherty A, Jackson D, Hammerla N, et al. . Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank study. PLoS One 2017;12:1–14. 10.1371/journal.pone.0169649
    1. Full KM, Kerr J, Grandner MA, et al. . Validation of a physical activity accelerometer device worn on the hip and wrist against polysomnography. Sleep Health 2018;4:209–16. 10.1016/j.sleh.2017.12.007
    1. Actigraph L. Activity monitor comparison, 2020. Available:
    1. Hajduk AM, Chaudhry SI. Sedentary behavior and cardiovascular risk in older adults: a scoping review. Curr Cardiovasc Risk Rep 2016;10. 10.1007/s12170-016-0485-6. [Epub ahead of print: 29 01 2016].
    1. Bertisch SM, Pollock BD, Mittleman MA, et al. . Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep heart health study. Sleep 2018;41:1–9. 10.1093/sleep/zsy047
    1. Gottlieb DJ, Redline S, Nieto FJ, et al. . Association of usual sleep duration with hypertension: the sleep heart health study. Sleep 2006;29:1009–14. 10.1093/sleep/29.8.1009
    1. Wolk R, Gami AS, Garcia-Touchard A, et al. . Sleep and cardiovascular disease. Curr Probl Cardiol 2005;30:625–62. 10.1016/j.cpcardiol.2005.07.002
    1. D'Agostino RB, Vasan RS, Pencina MJ, et al. . General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008;117:743–53. 10.1161/CIRCULATIONAHA.107.699579
    1. Alan K, Patricia M, Dan C. Understanding the health system use of ambulatory care patients. Winnipeg: Manitoba Centre for Health Policy, University of Manitoba, 2013.
    1. Randy F, Patricia M. Sex differences in health status, health care use, and quality of care: a population-based analysis for manitoba’s regional health authorities. Winnipeg: Manitoba Centre for Health Policy, 2005.
    1. Surveillance and Epidemiology Division, Centre for Chronic Disease Prevention, Public Health Agency of Canada . Chronic disease and injury indicator framework: quick STATs, fall 2014 edition. Chronic Dis Inj Can 2014;34:272–5. 10.24095/hpcdp.34.4.12
    1. Bauer G. Making sure everyone counts: considerations for inclusion, identification and analysis of transgender and transsexual participants in health surverys. CIHR Inst Gend Heal - Webinar Ser Integr Gend Sex Heal Res, 2012. Available:
    1. Tate CC, Ledbetter JN, Youssef CP. A two-question method for assessing gender categories in the social and medical sciences. J Sex Res 2013;50:767–76. 10.1080/00224499.2012.690110
    1. Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x
    1. Rosenberg M. Society and the adolescent Self-Image. Am Assoc Adv Sci 1965;148:804.
    1. Pilote L, Karp I. GENESIS-PRAXY (gender and sex determinants of cardiovascular disease: from bench to beyond-Premature acute coronary syndrome). Am Heart J 2012;163:741–6. 10.1016/j.ahj.2012.01.022
    1. Beaudreau SA, Spira AP, Stewart A, et al. . Validation of the Pittsburgh sleep quality index and the Epworth Sleepiness scale in older black and white women. Sleep Med 2012;13:36–42. 10.1016/j.sleep.2011.04.005
    1. NEFF KD. The development and validation of a scale to measure Self-Compassion. Self and Identity 2003;2:223–50. 10.1080/15298860309027
    1. SW JG. The multidimensional health questionnaire. Am J Health Behav 1996;21:33–42.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa